Our two HR+ BC cell lines retained the main characteristics of HR+ mammary epithelial cells in terms of cell morphology and marker expression, despite the loss of PR in MCF-7 and weak gain of ERBB2 in T47D (Figure S1). This evidence concerns the gene ERBB2 and breast cancer.